FDA Orange Book · active-ingredient family
Chlorothiazide; methyldopa
Chlorothiazide; methyldopa: 1 brand, 2 generics; first approved Nov 06, 1987; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available — 2 ANDA applications approved.
Brands (NDA)
1
Generics (ANDA)
2
Listed patents
0
Presentations
4
Originator applications
Brand (NDA) products
MERCKNDA 016016—2 strengths
MERCKNDA 016016—2 strengths
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 150MG;250MG | TABLET | ORAL | Discontinued | — |
| 250MG;250MG | TABLET | ORAL | Discontinued | — |
Abbreviated applications
Generic (ANDA) products (2)
PAR PHARMANDA 0707831987
PAR PHARMANDA 0707831987
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 150MG;250MG | TABLET | ORAL | Discontinued | — |
PAR PHARMANDA 0706541987
PAR PHARMANDA 0706541987
| Strength | Dosage form | Route | Status | TE |
|---|---|---|---|---|
| 250MG;250MG | TABLET | ORAL | Discontinued | — |
Orange Book patent file
Listed patents
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
FDA approval span
Approval history
First approval
Nov 06, 1987
39 yr 3 mo ago
Most recent approval
Nov 06, 1987
39 yr 3 mo ago
All 3 applications were approved in 1987.
Brand (NDA) 133%
Generic (ANDA) 267%
Chlorothiazide; methyldopa — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

